Objective: RDW is a measure of the variation of red blood cell width, reported as part of standard complete blood count; many paper reported results about the role of RDW in heart failure; the role of RDW in Acute Coronary Syndromes (ACS) is less known.
INTRODUCTION
Red blood cells distribution width (RDW) is a measure of red blood cell width variation, reported as part of a standard complete blood count; although it is usually measured, as a routine test, actually its values have been only used in the differential diagnosis of anaemia and high values indicate the presence of anisocytosis [1] .
Recently it has been demonstrated that RDW could be considered an independent prognostic marker of cardiovascular events in patients with heart failure and peripheral artery diseases [1, 2] . Some Authors studied the role or RDW as a predictor of mortality in patients with heart failure [3, 4] ; others analyzed the relation between NT-proBNP and RDW in these patients [5] ; however the role of RDW in patients with acute coronary syndromes (ACS) is less known; there are in literature some data regarding the role of RDW in short-term outcomes in these patients [6] ; some authors analyzed sixmonths outcomes, finding an independent association between higher RDW values and adverse outcomes [7] . However, the mechanism by which RDW is related to a poor prognosis in patients with ACS is still unclear.
Our aim was to study the pattern of RDW in the acute phase of an ACS and its relationship with other variables. 
MATERIALS AND METHODS
In our prospective study we enrolled 171 consecutive patients, admitted to the coronary care unit of our hospital between October 2011 and September 2012. The study was approved by the ethical committee of our hospital.
Patients were included in the analysis if they had a diagnosis of acute coronary syndrome documented by the evidence of obstructive coronary lesions on coronary angiography.
Our population included patients with unstable angina, non-ST-segment elevation myocardial infarction (NSTEMI), ST-segment elevation myocardial infarction (STEMI).
Clinical and biochemical data of each patient were collected in an electronic database. All patients referred had a full medical history (with information regarding lifestyle, clinical history, cardiovascular risk factors, presence of other pathologies like renal failure and diabetes mellitus), a physical examination, an echocardiogram, a 12-lead electrocardiogram, a coronary angiography; routine blood tests, including a complete blood count, myocardial necrosis markers, lipid profile, CRP, thyroid profile, renal function profile were carried out by our biochemistry department.
In our laboratory, normal reference range of RDW in human blood is 11.6-14.6%.
We divided the population in two groups, depending on RDW values: Group 1, including patients with normal values of RDW; Group 2, including patients with RDW values over the normal range.
STATISTIC ANALYSIS
Data analysis was performed using the GraphPad Prism 5.
Continuous variables are presented as mean ± standard deviation and were compared using Student's unpaired test. Categorical variables are presented as frequency counts and percentages and were calculated with the "Chi-square" test when appropriate; otherwise, Fisher's exact test was used. P value equal or less than 0.05 was considered statistically significant.
RESULTS

Patients Characteristics
The baseline characteristics of population are described in Table 1 .
Of the 171 patients who were enrolled, 104 were included in group 1, while 67 were included in group 2. Patient with high RDW values were significantly older (group 1: 64.44 y ± 1.118; group 2: 68.93 y ± 1.263; p=0.01), with a greater percentage of female patients (29% in group 2; 16% in group 1). The two groups were comparable regarding prevalence of hypertension, dyslipidemia, obesity, diabetes mellitus, smoking habits and domiciliary pharmacological treatment.
RDW and Left Ventricular Systolic Function
The left ventricular systolic function of two groups of patients was analyzed, by measuring the Ejection Fraction (EF) with echocardiography and a greater EF we found in patients of group 1 (mean values: 47.98% ± 0.9520), than in patients belonging to group 2 (mean values 44.52 % ± 1.469); the difference was statistically significant: p=0.03, Fig. (1) .
Moreover, only 4% of patients belonging to group 1 had an EF lower than 30%, instead of 22% of patients belonging to group 2.
RDW and NT-proBNP
N-terminal brain natriuretic peptide (NT-proBNP) levels were measured in each patient the day after the admission in our intensive care unit: comparing values of two groups we found a statistically significant difference (p=0.001), with greater values of NT-proBNP in patients of group 2 (mean 
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RDW and Estimated Glomerular Filtration Rate
A possible relation between high value of RDW and renal function was analyzed; the glomerular filtration rate (eGFR) of each patient was measured by calculating it with CKD-EPI formula; our data showed a lower eGFR in patients of group 2, than in patients of group 1 (mean values of group1: 83.24 ml/min/1,73m 2 ± 2.181; group 2: 67.27 ml/min/1,73m 2 ± 3.786; p=0.0001; (Fig. 3) .
DISCUSSION
The role of RDW in patients with acute coronary syndrome has not been investigated as well as its role in patients with heart failure.
Many papers have demonstrated the role of RDW in patients with heart failure: according to Al-Najjar http://eurjhf.oxfordjournals.org/content/11/12/1155. longcorresp-1 et al. [8] , RDW has an independent prognostic power in these patients. They analyzed a cohort of patients with heart failure, comparing power of RDW with NT- Fig. (2) . Relationship between RDW and NT-proBNP levels. proBNP, and they suggested that the two factors can be considered similar in predicting cardiovascular events, and independent from each other.
Moreover, the role of RDW as a predictor of mortality in patients with heart failure was investigated: Pascual-Figal et al analyzed a cohort of 628 consecutive patients with acute heart failure finding that higher RDW levels at discharge were associated with worse long-term outcome regardless of haemoglobin levels and anaemia status (3) . A role in the prognosis was established also for patients with diastolic heart failure in a study on the relationship between RDW and NT-proBNP [9] .
However, there is evidence that RDW could be considered a predictor of death and other cardiovascular events also in patients with coronary artery diseases, as Tonelli et al have shown [10] ; other studies confirmed these results: Wang et al analyzed the role of RDW in short-term outcomes in patients with ACS in a chinese population: they enrolled 1654 patients with ACS, dividing them into four groups according to quartiles of baseline RDW and they found that elevated RDW calues could predict an increased risk of short-term adverse outcomes in these patients [6] .
However, nowadays there are no evidence about the possible mechanism that leads to a poorer prognosis in patients with ACS.
In literature, there is also evidence of the relation between RDW and renal function: Forhècz et al studied 195 patients with systolic heart failure to validate recent observations on the predictive role of RDW for outcomes in chronic heart failure; during this observational study, they found that RDW was correlated to an ineffective erythropoiesis, undernutrition and impaired renal function [11] ; according to these data, Lippi et al studied 8585 adult outpatients over a 3-year period and they found an inverse, graded, association between RDW and kidney function [12] .
Our results suggest that RDW can provide information concerning the severity of clinical condition in the acute phase of an ACS and a relation with poor prognostic factors as a reduced systolic function and an impaired glomerular filtration rate; these data confirmed evidence of literature, according to which RDW should be related to heart failure and to a lower renal function.
In our opinion, these evidences could partially explain the poorer prognosis of patients with ACS and elevated levels of RDW, characterized by a greater prevalence of mortality and new cardiovascular events, as reported in literature.
CONCLUSIONS
Since this measurement of RDW is included in the routine tests to which every patient admitted to the hospital should be submitted, as part of peripheral blood counts, RDW appears to be a non expensive and easy to obtain variable that should be taken into account in the overall assessment of patients with ACS, both during the acute phase of an ACS, and during follow-up of these patients.
